Clinical experience with ceraxon used in ischemic stroke
Citicoline (Ceraxon) is a neuroprotective agent used in acute ischemic stroke (IS) and chronic cerebrovascular diseases. The efficiency and safety of Ceraxon intravenously in a dose of2000 mg/day for 10 days, then orally for 35 days with evaluation of its effect on cognitive functions were studied i...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
IMA-PRESS LLC
2010-09-01
|
| Серія: | Неврология, нейропсихиатрия, психосоматика |
| Предмети: | |
| Онлайн доступ: | https://nnp.ima-press.net/nnp/article/view/60 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|